Jordi Teixido

Dr. Jordi Teixido

Organic and Pharmaceutical Chemistry, Institut Químic de Sarrià, Barcelona, Catalonia, Spain
orcid

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2007 in Current Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
JSJ. C. Stockert
J. C. Stockert
MCM. Canete
M. Canete
Angeles JuarranzAngeles Juarranz
Angeles Juarranz
AVA. Villanueva
A. Villanueva
RHR. W. Horobin
R. W. Horobin
SNSanti Nonell
Santi Nonell
The photodynamic process induces cell damage and death by the combined effect of a photosensitizer (PS), visible light, and molecular oxygen, which generate singlet oxygen (1O2) and other reactive oxygen species that are responsible for cytotoxicity. The most important application of this process with increasing biomedical interest is the photodynamic therapy (PDT) of cancer. In addition to hematoporphyrin-based drugs, 2nd generation PSs with better photochemical properties are now studied using cell cultures, experimental tumors and clinical trials. Porphycene is a structural isomer of porphyrin and constitutes an interesting new class of PS. Porphycene derivatives show higher absorption than porphyrins in the red spectral region (lλ > 600 nm, η > 50000 M-1·cm-1) owing to the lower molecular symmetry. Photophysical and photobiological properties of porphycenes make them excellent candidates as PSs, showing fast uptake and diverse subcellular localizations (mainly membranous organelles). Several tetraalkylporphycenes and the tetraphenyl derivative (TPPo) induce photodamage and cell death in vitro. Photodynamic treatments of cultured tumor cells with TPPo and its palladium(II) complex induce cytoskeletal changes, mitotic blockage, and dose-dependent apoptotic or necrotic cell death. Some pharmacokinetic and phototherapeutic studies on experimental tumors after intravenous or topical application of lipophilic alkylsubstituted porphycene derivatives are known. Taking into account all these features, porphycene PSs should be very useful for PDT of cancer and other biomedical applications.

13 April 2009 in Journal of Chemical Information and Modeling
Verified
Journal Article
Closed access
VPVioleta I. Pérez-Nueno
Violeta I. Pérez-Nueno
ORObdulia Rabal
Obdulia Rabal
JBJose I. Borrell
Jose I. Borrell
Jordi TeixidoJordi Teixido
Jordi Teixido

28 February 1998 in The Journal of Physical Chemistry B
Verified
Journal Article
Closed access
CCCarles Colominas
Carles Colominas
Jordi TeixidoJordi Teixido
Jordi Teixido
JCJose Cemelí
Jose Cemelí
FLF. Javier Luque
F. Javier Luque
MOModesto Orozco
Modesto Orozco

1 July 2003 in Tetrahedron Letters
Verified
Journal Article
Closed access
NMNúria Mont
Núria Mont
Jordi TeixidoJordi Teixido
Jordi Teixido
JBJose I. Borrell
Jose I. Borrell
CKC. Kappe
C. Kappe

30 March 2022 in Molecules
Verified
Journal Article
Open access
PDF file
ADAna Donaire-Arias
Ana Donaire-Arias
AMAna Maria Montagut
Ana Maria Montagut
RBRaimon Puig De La Bellacasa
Raimon Puig De La Bellacasa
RERoger Estrada-Tejedor
Roger Estrada-Tejedor
Jordi TeixidoJordi Teixido
Jordi Teixido
JBJose I. Borrell
Jose I. Borrell
Pyrazolo[3,4-b]pyridines are a group of heterocyclic compounds presenting two possible tautomeric forms: the 1H- and 2H-isomers. More than 300,000 1H-pyrazolo[3,4-b]pyridines have been described which are included in more than 5500 references (2400 patents) up to date. This review will cover the analysis of the diversity of the substituents present at positions N1, C3, C4, C5, and C6, the synthetic methods used for their synthesis, starting from both a preformed pyrazole or pyridine, and the biomedical applications of such compounds.

1 May 1995 in Tetrahedron Letters
Verified
Journal Article
Closed access
SNSantiago Nonell
Santiago Nonell
NBNúria Bou
Núria Bou
JBJose I. Borrell
Jose I. Borrell
Jordi TeixidoJordi Teixido
Jordi Teixido
AVAngeles Villanueva
Angeles Villanueva
MCMagdalena Cañete
Magdalena Cañete